Key Genes and Prognostic Analysis in HER2+ Breast Cancer
Human epidermal growth factor 2 (HER2)+ breast cancer is considered the most dangerous type of breast cancers. Herein, we used bioinformatics methods to identify potential key genes in HER2+ breast cancer to enable its diagnosis, treatment, and prognosis prediction. Datasets of HER2+ breast cancer a...
Main Authors: | Yujie Weng MS, Wei Liang MS, Yucheng Ji MS, Zhongxian Li MS, Rong Jia MS, Ying Liang MS, Pengfei Ning MS, Yingqi Xu PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/1533033820983298 |
Similar Items
-
Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review
by: Chaokun Wang MS, et al.
Published: (2020-09-01) -
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
by: Rong Jia, et al.
Published: (2020-10-01) -
Xiao-Ai-Ping Injection Enhances Effect of Paclitaxel to Suppress Breast Cancer Proliferation and Metastasis via Activating Transcription Factor 3
by: Junjun Chen PhD, et al.
Published: (2020-04-01) -
D-Dimer to Fibrinogen Ratio as a Novel Prognostic Marker in Patients After Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study
by: Yan Bai MS, et al.
Published: (2020-08-01) -
Prognostic Value of Podoplanin in Various Tumors
by: Xiaohang Wang PhD, et al.
Published: (2021-09-01)